Back

Magnetic drug targeting to vascular injury regions and atherosclerotic lesions: in vivo pilot study

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 4 - Inflammation and microcirculation Drugs, Drug Targets ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Iwona Cicha

Friedrich Alexander University Erlangen Nuernberg, Erlangen (Germany)

7 More presentations in this session

Presentation thumbnail
Adiponectin forms a complex with electronegative L5 LDL in human plasma and inhibits its atherogenic effects
Professor T. Sawamura (Matsumoto, JP)
Abstract
Presentation thumbnail
Nicotine promotes atherosclerosis development in apolipoprotein E-deficient mice through alpha 1 nicotinic acetylcholine receptor on RAW264.7 and MOVAS cells
Mr A. Ren (Shanghai, CN)
Presentation thumbnail
miR-147 deficiency in macrophages exacerbates atherosclerosis in mice
Mrs M. Nazari Jahantigh (Munich, DE)
Abstract
Presentation thumbnail
Atheroprotective effects of ticagrelor, a P2Y12 antagonist, in apolipoprotein-E-deficient mice
Doctor B. Ganbaatar (Tokushima, JP)
Abstract
Presentation thumbnail
Deletion of cyclophilin d inhibits atherosclerotic plaque formation in apolipoprotein-e deficient mice
Doctor R. Umezu (Fukuoka, JP)
Abstract

Access the full session

Session thumbnail
Poster Session 4 - Inflammation and microcirculation

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources